We knew the CF33 is powerful itself and also crucial to the be succeeded in novel therapies CF33-CD19
and
Our management had a pre-IND meeting with FDA and received feedback and guidance back in Aug 2020
This important feedback from FDA would provide us with a clear roadmap for a successful IND submission and clinical development of CF33
Since we are in-licencing CF33 about 1.5 years ago, our management took every step seriously and carefully to make sure we will have a successful and fast pathway and now we are at the doorstep
The IND approvals will be announced soon, any days
We knew the CF33 is powerful itself and also crucial to the be...
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $422.5M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.308M | 22.90M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 812657 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 1087666 | 13 |
View Market Depth
| Last trade - 15.33pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |